Grant Private Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$411K Sell
820
-97
-11% -$46.6K 0.17% 107
2026
Q1
$451K Sell
917
-5
-0.5% -$2.71K 0.24% 88
2025
Q4
$534K Sell
922
-21
-2% -$11.9K 0.32% 67
2025
Q3
$457K Buy
+943
New +$439K 0.28% 75
2025
Q2
Sell
-808
Closed -$402K 138
2025
Q1
$402K Sell
808
-18
-2% -$9.75K 0.43% 67
2024
Q4
$440K Buy
+826
New +$454K 0.47% 54

Other funds holding TMO

Grant Private Wealth Management's TMO Position: Q2 2026 in Review

Grant Private Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 11% in Q2 2026, selling an estimated $46.6K and leaving 820 shares worth $411K. The position accounts for 0.17% of the portfolio, ranked #107.

Grant Private Wealth Management first reported a position in TMO in Q4 2024 and has held it in 6 quarters since. The position peaked at $534K in Q4 2025. 429 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Grant Private Wealth Management held 820 shares of Thermo Fisher Scientific worth $411K as of Q2 2026.
  • Grant Private Wealth Management sold 97 Thermo Fisher Scientific shares in Q2 2026, an estimated $46.6K.
  • Thermo Fisher Scientific made up 0.17% of Grant Private Wealth Management's portfolio in Q2 2026, its #107 holding.
  • Grant Private Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 6 quarters since.
  • Grant Private Wealth Management's Thermo Fisher Scientific position peaked at $534K in Q4 2025.
  • 429 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Grant Private Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.